Key Outcomes Amongst Chemotherapy Sufferers:
- 90% discount in mortality
- 79% discount in inpatient days
- 52% shorter inpatient stays
- Fevers detected usually 72 hours or extra earlier than signs
- 120-day common put on time per affected person
“TempShield gave us a important head begin in detecting infections—permitting well timed intervention, avoiding critical issues, and saving lives,” stated Dr. Tallat Mahmood, Medical Director at Roswell Park Most cancers Middle at Ellis Drugs. “This research exhibits that long-term temperature monitoring advantages not simply high-risk sufferers, however all chemotherapy sufferers.”
Additionally Learn: AiThority Interview with Nicole Janssen, Co-Founder and Co-CEO of AltaML
This research additionally challenges the prevailing scientific deal with fever detection solely in sufferers thought of at highest danger—equivalent to these with neutropenia or cytokine launch syndrome (CRS). The research exhibits {that a} far broader group of chemotherapy sufferers can dramatically profit from using this gadget. Extending TempShield to all sufferers present process immune-suppressing therapy has the potential to stop issues and save many extra lives.
“The true hazard in most cancers care isn’t simply the illness—it’s the issues we miss,” stated Sam Barend, CEO of AION Biosystems. “TempShield is a game-changer: small, easy, and inexpensive, and it’s serving to save lives by catching infections earlier than signs seem—similar to the blood glucose monitor did for diabetes.”
“The Keep Nicely Program was born out of an pressing purpose: to cut back pointless hospitalizations in our group,” stated Mayor Gary McCarthy. “We selected to begin with most cancers sufferers as a result of they face among the highest hospitalization charges—and I believed we might do higher by intervening earlier. TempShield has confirmed that we are able to. Schenectady is exhibiting what’s attainable when a metropolis places well being innovation into motion.”
The Resolution: Accessible, Scalable, Recreation-Altering
- 99% of sufferers have been eligible for insurance coverage reimbursement
- Over 50% of sufferers paid no copay
“The TempShield is without doubt one of the most sensible innovations I might think about for a most cancers affected person. I do know it saved my life,” stated Amy Raddick, a stage 4 breast most cancers affected person handled at Roswell Park Most cancers Middle at Ellis Drugs website.
The success of the Ellis research has been mirrored in real-world use at NY Most cancers and Blood—one of many nation’s largest oncology doctor teams—the place AION TempShield has been utilized on over 2,000 sufferers with equally dramatic outcomes.
“Our mission is to ship the perfect most cancers care on the proper time. TempShield helps us do exactly that by empowering our groups to stop pointless hospitalizations,” says Dr. Jeff Vacirca, Oncologist and CEO of New York Most cancers & Blood Specialists.
AION TempShield™ is the blood glucose monitor for most cancers care:
- First FDA-cleared wearable designed particularly for oncology sufferers
- First wearable gadget deployed for long-term use throughout chemotherapy sufferers — used on extra most cancers sufferers than some other wearable thermometer
- First medical gadget distributed by Cencora (previously Amerisource Bergen)
- First distant monitoring gadget built-in into Flatiron Well being’s OncoEMR — essentially the most broadly used oncology-specific EHR within the U.S.
[To share your insights with us, please write to psen@itechseries.com]
